Bausch Health
BHC
#3383
Rank
S$4.55 B
Marketcap
$12.38
Share price
-0.85%
Change (1 day)
33.06%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.58

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.52. In 2022 the company made an earnings per share (EPS) of -$0.82 an increase over its 2021 EPS that were of -$3.52.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.58334.93%
2022-$0.82-76.64%
2021-$3.5268.45%
2020-$2.09-68.91%
2019-$6.73-57.11%
2018-$15.69-272.22%
2017$9.11-199.29%
2016-$9.17798.7%
2015-$1.02-128.31%
2014$3.61-204.62%
2013-$3.45602.7%
2012-$0.49-171.15%
2011$0.69-143.96%
2010-$1.57-206.57%
2009$1.47-11.2%
2008$1.662.46%
2007$1.62-7.58%
2006$1.75-14.29%
2005$2.0454%
2004$1.33-500%
2003-$0.33-141.67%
2002$0.80-4.76%
2001$0.84-175%
2000-$1.11-268%
1999$0.6614.94%
1998$0.5820.83%
1997$0.4853.83%
1996$0.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.33-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.36-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA